""Under Section 10.2 of the current version of the PFL ADP, the default period of ineligibility for the use of a prohibited substance is six months but can be increased up to a year in certain circumstances. Here, Moore received a one-year period of ineligibility because his reckless conduct-injecting an unlabeled drug that did not belong to him-led to his positive test. Moore's one-year period of ineligibility began on April 9, 2025, the date his positive sample was collected.""
"Moore, who faced Corey Anderson last year for the Bellator light heavyweight championship, has been suspended 12 months, six more than normal, for his first infraction under the PFL's Anti-Doping Policy, which is administered by USADA (the U.S. Anti-Doping Agency, who previously spearheaded the UFC's anti-doping program). Per a press release issued on Thursday, Moore (12-4) "tested positive for recombinant erythropoietin (rEPO) as the result of an out-of-competition sample collected on April 9, 2025.""
Karl Moore received a one-year period of ineligibility after testing positive for recombinant erythropoietin (rEPO) from an out-of-competition sample collected April 9, 2025. USADA administers the PFL Anti-Doping Policy and applied the increased sanction. The default ineligibility under Section 10.2 is six months but can increase to one year; Moore received the maximum because injecting an unlabeled drug that did not belong to him was deemed reckless conduct. The suspension was backdated to April 9, 2025. Moore holds a 12-4 record, previously challenged Corey Anderson for the Bellator light heavyweight title, and lost a split decision to Antonio Carlos Junior on May 1 at the PFL World Tournament.
Read at Cageside Press
Unable to calculate read time
Collection
[
|
...
]